Fleming GF - Search Results

1

Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.

Nimeiri HS, Oza AM, Morgan RJ, Friberg G, Kasza K, Faoro L, Salgia R, Stadler WM, Vokes EE, Fleming GF; Chicago Phase II Consortium; PMH Phase II Consortium; California Phase II Consortium. Nimeiri HS, et al. Among authors: fleming gf. Gynecol Oncol. 2008 Jul;110(1):49-55. doi: 10.1016/j.ygyno.2008.02.009. Epub 2008 Apr 18. Gynecol Oncol. 2008. PMID: 18423560 Free PMC article. Clinical Trial.

2

Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies.

Mundt AJ, Rotmensch J, Waggoner S, Quiet C, Fleming G. Mundt AJ, et al. Gynecol Oncol. 1999 Jan;72(1):45-50. doi: 10.1006/gyno.1998.5212. Gynecol Oncol. 1999. PMID: 9889028 Clinical Trial.

3

Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies.

Mundt AJ, Roeske JC, Lujan AE, Yamada SD, Waggoner SE, Fleming G, Rotmensch J. Mundt AJ, et al. Gynecol Oncol. 2001 Sep;82(3):456-63. doi: 10.1006/gyno.2001.6250. Gynecol Oncol. 2001. PMID: 11520140 Clinical Trial.

4

Intraperitoneal chemotherapy for ovarian cancer.

Friberg G, Fleming G. Friberg G, et al. Curr Oncol Rep. 2003 Nov;5(6):447-53. doi: 10.1007/s11912-003-0004-z. Curr Oncol Rep. 2003. PMID: 14521802 Review.

5

Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.

Mundt AJ, Rotmensch J, Waggoner SE, Yamada SD, Fleming GF. Mundt AJ, et al. Among authors: fleming gf. Gynecol Oncol. 2004 Mar;92(3):801-5. doi: 10.1016/j.ygyno.2003.10.017. Gynecol Oncol. 2004. PMID: 14984944 Clinical Trial.

6

A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.

Gupta S, Mauer AM, Ryan CW, Taber DA, Samuels BL, Fleming GF; University of Chicago Phase II Network. Gupta S, et al. Among authors: fleming gf. Am J Clin Oncol. 2005 Feb;28(1):65-9. doi: 10.1097/01.coc.0000139020.58780.de. Am J Clin Oncol. 2005. PMID: 15685037 Clinical Trial.

7

A phase I trial of gemcitabine and topotecan in previously treated ovarian or peritoneal cancer: a Gynecologic Oncology Group study.

Chen MD, Fleming GF, Mitchell S, Horowitz I. Chen MD, et al. Among authors: fleming gf. Gynecol Oncol. 2006 Jan;100(1):111-5. doi: 10.1016/j.ygyno.2005.07.114. Epub 2005 Sep 8. Gynecol Oncol. 2006. PMID: 16150481 Clinical Trial.

8

A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study.

Armstrong DK, Fleming GF, Markman M, Bailey HH. Armstrong DK, et al. Among authors: fleming gf. Gynecol Oncol. 2006 Nov;103(2):391-6. doi: 10.1016/j.ygyno.2006.02.029. Epub 2006 Apr 19. Gynecol Oncol. 2006. PMID: 16626792 Clinical Trial.

9

Chemotherapy in endometrial cancer.

Obel JC, Friberg G, Fleming GF. Obel JC, et al. Among authors: fleming gf. Clin Adv Hematol Oncol. 2006 Jun;4(6):459-68. Clin Adv Hematol Oncol. 2006. PMID: 16981669 Review.

10

Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.

Modesitt SC, Tian C, Kryscio R, Thigpen JT, Randall ME, Gallion HH, Fleming GF; Gynecologic Oncology Group. Modesitt SC, et al. Among authors: fleming gf. Gynecol Oncol. 2007 Apr;105(1):59-65. doi: 10.1016/j.ygyno.2006.10.045. Epub 2006 Dec 5. Gynecol Oncol. 2007. PMID: 17150247 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters